Long-COVID is relatively infrequent, but still poses a threat
A new study suggests that long COVID complaints may not be common among COVID-19 patients as compared to the general population.
Source: news-medical.net
Page 38 - Research Square News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Research Square. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Research Square Today - Breaking & Trending Today
Fourth dose of Covid-19 vaccine 75% effective vs Omicron – Thai study – Manila Bulletin
A fourth dose of the AstraZeneca Covid-19 vaccine was found to be around 75 percent effective against infection of the highly transmissible Omicron variant, according to a real-world evidence study conducted by the Chiang Mai University in Thailand. The study was designed to "evaluate the vaccine
Source: mb.com.ph
New Study Adds To Growing Body Of Evidence Suggesting Mask Mandates Are Ineffective
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
Source: zerohedge.com
The clinical, epidemiological, and evolutionary consequences of a potential SARS-CoV-2-related bat virus spillover into humans
A team of scientists from France has recently described the epidemiological and clinical consequences of a bat sarbecovirus infection in humanized mice.
Source: news-medical.net
Vaxzevria 73% effective at preventing Omicron-related infections after fourth dose, according to real-world evidence study in Thailand
Vaccine effectiveness similar across all vaccines studied
Source: nationthailand.com